Council for Innovation Promotion

Fact Check: Debunking Myths About Patents in the Pharmaceutical Industry

Activists affiliated with the Initiative for Medicines, Access & Knowledge (I-MAK) and R Street Institute have propagated false narratives about how patents stifle competition in the drug industry and keep generic drugs from coming to market. These erroneous arguments include the ideas that drug developers ‘game’ the FDA’s Orange Book, that they file unnecessary patents […]

Fact Check: Debunking Myths About Patents in the Pharmaceutical Industry Read More »

C4IP Coalition Updates: October 2024

October was a productive month for C4IP! Here’s a roundup of all that we accomplished over the past month. October Highlights: Spotlighting New Insights on Patent Quality On September 30, the nonprofit, nonpartisan Sunwater Institute released a policy report, “Patent Quality in the United States: Findings and Suggestions for Policymakers.” The report reviewed the U.S.

C4IP Coalition Updates: October 2024 Read More »

New Op-Ed from C4IP Co-Chair Andrei Iancu: Bill Is Key To Protecting US Economy From Patent Piracy, 10/25/2024

C4IP Co-Chair and former USPTO Director Andrei Iancu recently published an opinion piece in Law360 highlighting the importance of passing the bipartisan RESTORE Patent Rights Act. This bill, introduced by Senators Chris Coons (D-DE) and Tom Cotton (R-AR) and Representatives Nathaniel Moran (R-TX) and Madeleine Dean (D-PA), would reinstate injunctions as the default remedy in

New Op-Ed from C4IP Co-Chair Andrei Iancu: Bill Is Key To Protecting US Economy From Patent Piracy, 10/25/2024 Read More »

Blog: Fact Check: The RESTORE Patent Rights Act Would Bolster America’s Innovation Economy, 10/18/2024

The RESTORE Patent Rights Act, introduced in July by a bipartisan group of senators and representatives, would be a pivotal legislative milestone for promoting innovation, if enacted into law. This bill would reestablish injunctive relief as the default legal remedy for patent infringement, preventing patent infringers from using others’ IP and ultimately facing little more

Blog: Fact Check: The RESTORE Patent Rights Act Would Bolster America’s Innovation Economy, 10/18/2024 Read More »

New Op-Ed from C4IP Co-Chairs Andrei Iancu and David Kappos: Proposed Drug Patent Reforms Would Do More Harm Than Good

C4IP Co-Chairs and former USPTO Directors Andrei Iancu and David Kappos recently published an opinion piece in RealClear Health highlighting the unintended consequences that would arise if the Medication Affordability and Patent Integrity Act (MAPIA) is passed by Congress and signed into law. Supporters of the bill argue that drug companies take advantage of a

New Op-Ed from C4IP Co-Chairs Andrei Iancu and David Kappos: Proposed Drug Patent Reforms Would Do More Harm Than Good Read More »

C4IP Coalition Updates: September 2024

September was a productive month for C4IP! Here’s a roundup of all that we accomplished over the past month. September Highlights: Advancing the Patent Eligibility Restoration Act The Patent Eligibility Restoration Act (PERA) remains one of the most important innovation policy reforms on the legislative agenda. This bill would promote research and investment in high-tech

C4IP Coalition Updates: September 2024 Read More »

Scroll to Top